Correlation Between Fairfax Financial and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both Fairfax Financial and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fairfax Financial and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fairfax Financial Holdings and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Fairfax Financial and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fairfax Financial with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fairfax Financial and Cardiol Therapeutics.

Diversification Opportunities for Fairfax Financial and Cardiol Therapeutics

-0.21

Correlation Coefficient

Fairfax Financial  Cardiol Therapeutics

Very good diversification

The 3 months correlation between Fairfax and Cardiol is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Fairfax Financial Holdings and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Fairfax Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fairfax Financial Holdings are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Fairfax Financial i.e., Fairfax Financial and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between Fairfax Financial and Cardiol Therapeutics

Assuming the 90 days trading horizon Fairfax Financial Holdings is expected to generate 0.24 times more return on investment than Cardiol Therapeutics. However, Fairfax Financial Holdings is 4.21 times less risky than Cardiol Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.07 per unit of risk. If you would invest  195,663  in Fairfax Financial Holdings on December 3, 2024 and sell it today you would earn a total of  12,340  from holding Fairfax Financial Holdings or generate 6.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Fairfax Financial Holdings  vs.  Cardiol Therapeutics Class

Fairfax Financial

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Fairfax Financial Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical indicators, Fairfax Financial is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Cardiol Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Fairfax Financial and Cardiol Therapeutics

The main advantage of trading using opposite Fairfax Financial and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fairfax Financial position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind Fairfax Financial Holdings and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.